SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Transpek Industry Ltd (TRANSPEK)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506687 NSE: TRANSPEK Chemicals | Small Cap | Transpek Industry Share Price

₹981.90 4.35 (0.44%)

As on 12-Jun'26 10:38

Transpek Industry Ltd (TRANSPEK)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506687 NSE: TRANSPEK Chemicals | Small Cap | Transpek Industry Share Price

₹981.90 4.35 (0.44%)

As on 12-Jun'26 10:38

Key Metrics
Valuation Multiples
Market Cap
₹546 Cr.
Current Price
₹981.9
52-Week Low / High
₹864 / 1,779
TTM EPS
₹81.7
TTM Sales
₹621 Cr.
Book Value per Share
₹1,374
P/E Ratio
11.96
Lower than its 5-year historical median
Industry PE
49.1
Price to Book (P/B)
0.71
Lower than its 5-year historical median
Price to Sales (P/S)
0.88
Lower than its 5-year historical median
EV/EBITDA
4.00
Lower than its 5-year historical median
Dividend Yield
1.60%
Profitability Efficiency
Return on Equity (ROE)
6.87%
Underperforms industry median
Return on Capital Employed (ROCE)
9.79%
Underperforms industry median
Return on Assets (ROA)
4.96%
Operating Profit Margin
15.8%
Net Profit Margin
7.5%
Gross Profit Margin
17.2%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
12.11%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
15.03%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
26.4%
Asset Quality
Promoter Holding
57.47%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹762 Cr.
Equity
₹5.6 Cr.
Face Value
₹10
All Time Low / High
₹6.90 / 2695.00

Transpek Industry stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Transpek Industry Ltd a good quality company?
Transpek Industry Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Transpek Industry Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Transpek Industry Ltd vs industry peers?
Transpek Industry Ltd revenue CAGR is 2.81%, compared to the industry median CAGR of 7.53%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Transpek Industry Ltd?
Promoters hold 57.47% of the Transpek Industry Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Transpek Industry Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 11.5% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Transpek Industry Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 27.6%23%12.6%26.6%24.3%7.8%17.4%20.7%10.1%9.8%-
Value Creation
Index
1.00.6-0.10.90.7-0.40.30.5-0.3-0.3-

Growth Parameters

Sales 284317361595566339599827580650621
Sales YoY Gr.-11.6%14.1%64.6%-4.9%-40%76.5%38%-29.9%12.1%-
Adj EPS 35.152.946117.9132.341118160.768.196.881.7
YoY Gr.-50.5%-13%156.2%12.2%-69%187.8%36.2%-57.6%42.1%-
BVPS (₹) 154.5368.1442.1557.5605.9680867.11,050.31,205.61,334.41,374
Adj Net
Profit
20.629.525.765.873.922.965.989.838.154.146
Cash Flow from Ops. 43.9477.412811134.447.111197.8135-
Debt/CF from Ops. 1.51.927.61.112.82.70.70.50.3-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 9.7%2.8%2.8%12.1%
Adj EPS 11.9%-6.1%-6.4%42.1%
BVPS27.1%17.1%15.5%10.7%
Share Price 10.4% -8.9% -22.8% -43.1%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
24.919.911.423.622.76.415.316.867.66
Op. Profit
Mgn %
1716.913.119.721.114.1171914.215.815
Net Profit
Mgn %
7.39.37.111.113.16.81110.96.68.37.4
Debt to
Equity
0.70.40.80.50.30.30.30.10.10.1-
Working Cap
Days
1361231561121111601049714011741
Cash Conv.
Cycle
6965704448825347715527

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales284317361595566339599827580650
Operating Expenses + 237264314478448292503680497555
Manufacturing Costs35343859674665767164
Material Costs124149192301260163315438287332
Employee Cost 32353745494451606267
Other Costs 454647737140721067792
Operating Profit 47534711711847961478295
Operating Profit Margin (%) 16.5%16.6%13.0%19.6%20.8%13.9%16.0%17.8%14.2%14.6%
Other Income + 471018171729182529
Exceptional Items 0000000000
Interest 1191219161011191412
Depreciation 891014262930333850
Profit Before Tax 3242351019426841135662
Tax 101293621219291713
Profit After Tax 21302666732365833949
PAT Margin (%) 7.5%9.5%7.3%11.1%12.9%6.9%10.9%10.1%6.7%7.5%
Adjusted EPS (₹)36.253.747.3117.7130.641.7117.1149.569.087.3
Dividend Payout Ratio (%)20.70%16.80%19%17%9.60%18%19.20%18.40%20.30%22.90%

Valuation of Transpek Industry - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 91206247311338380484587673745
Share Capital 6666666666
Reserves 85200241306333374479581668740
Debt +56701801207771105633029
Long Term Debt26258569454435282021
Short Term Debt3045955132277035109
Minority Interest0000000000
Trade Payables20345459523656544664
Others Liabilities 427785108121112118183217162
Total Liabilities 2093865665995895997648879661,001

Fixed Assets

Net Fixed Assets +94117179236287287295365397360
Gross Block180126197268343370380465530528
Accumulated Depreciation8691932568385100133168
CWIP 101356331914162465
Investments 5131144149118142196238321328
Inventories38374656503766656467
Trade Receivables4667939390769911892103
Cash Equivalents 4121122512531101
Others Assets 12204730252141515536
Total Assets 2093865665995895997648879661,001

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 44477128111344711198135
PBT 3242351019426841135662
Adjustment 19131930393435564157
Changes in Working Capital -12-36162-21-50-221326
Tax Paid -6-10-10-20-24-4-23-36-12-9
Cash Flow From Investing Activity + -16-31-103-45-33-17-70-13-32-30
Capex -17-37-119-47-37-14-38-45-38-19
Net Investments -001300-6-4330-2-23
Others 163334112911
Cash Flow From Financing Activity + -27-1796-83-77-39-94-64-56
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 01065-16-17-0-10-7-81
Interest Paid -10-8-12-18-13-9-9-13-10-9
Dividend Paid -3-5-6-6-20-1-4-13-15-8
Others -14-1349-43-26832-61-30-41
Net Cash Flow 1-10-0015-144348

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)25.7120.2311.6723.5522.456.4915.1415.596.126.87
ROCE (%)27.5822.9812.6226.5724.277.8117.4320.6610.119.79
Asset Turnover Ratio1.351.10.761.020.950.570.8810.630.66
PAT to CFO Conversion(x)2.11.570.271.941.521.480.721.342.512.76
Working Capital Days
Receivable Days79.1063.1080.7057.4059.1089.1053.3047.906654.60
Inventory Days40.4041.7041.7031.3034.1046.4031.3028.9040.7036.90
Payable Days96.7066.5083.8068.907898.8053.5046.1063.6060.10

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Transpek Industry Ltd FAQs

The current trading price of Transpek Industry on 12-Jun-2026 10:38 is ₹981.9.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 11-Jun-2026 the market cap of Transpek Industry stood at ₹546.0 Cr

The latest P/E ratio of Transpek Industry as of 11-Jun-2026 is 11.96.

The latest P/B ratio of Transpek Industry as of 11-Jun-2026 is 0.71.

The 52-week high of Transpek Industry is ₹1,779 and the 52-week low is ₹864.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Transpek Industry is ₹621 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Transpek Industry Ltd is a good quality company.

The key valuation ratios of Transpek Industry Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Transpek Industry Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Transpek Industry Ltd

Transpek Industry was set up in 1965 initially for manufacturing transparent acrylic sheets. The company has grown to become one of the leading manufacturers and exporters of a range of chemicals servicing the requirements of customers from a diverse range of industries - textiles, pharmaceuticals, agrochemicals, polymers, etc.
Transpek has evolved as a ‘first time’ manufacturer of several products in India and also pioneered the development of the market for the same.

With its expertise in handling chlorine and sulphur, the company has indigenously developed a process for chlorinated chemicals like Thionyl Chloride and Chloro Acetyl Chloride. Today the capacity for thionyl chloride at Transpek is the largest outside Europe.

Transpek used to manufacture sodium hydro sulphite, safolite, safoline, zinc oxide and zinc dust. This business since has been transferred to Transpek Silox Industry, a joint venture between Transpek & Silox.

Products

• Thionyl Chloride: 15000 TPA
• Chloro Acetyl Chloride: 900 TPA
• Sulphur Dichloride: 1500 TPA
• Sulphur Monochloride: 7500 TPA
• Oleum 65% : 12000 TPA
• Sulphur Trioxide: 10000 TPA
• Sulphuric Acid: 5000 TPA
• Sulphur Dioxide: 7500 TPA
• Acid Chlorides: 1200 TPA

Milestones

• In 1989, all members of Transpek received equity shares at face value, when the market price was over 20 times.
• In 1990, the company won a turnkey project in Iran to install and commission a chemical plant valuing $12.5 million, against competition from several world players.
• 1992, Financial Express, a leading Indian business daily, declared Transpek as the ‘Best Inorganic Chemical Company’ for two consecutive years.
• In 1996 Transpek commissioned the world’s largest manufacturing facility for Thionyl Chloride outside Europe.
• In 1997, its quality management system was awarded with ISO 9002 recognition from RWTUV of Germany.
• Transpek was recognized by the Government of India as an Export House.
• In 2000, the company’s quality management system was awarded ISO 14001 recognition from RWTUV of Germany

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: